<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2021.791545</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluation of a Newly Developed Smartphone App for Risk Factor Management in Young Patients With Ischemic Stroke: A Pilot Study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Fruhwirth</surname> <given-names>Viktoria</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Berger</surname> <given-names>Lisa</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gattringer</surname> <given-names>Thomas</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/378034/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Fandler-H&#x000F6;fler</surname> <given-names>Simon</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/531905/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kneihsl</surname> <given-names>Markus</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/815786/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Schwerdtfeger</surname> <given-names>Andreas</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/44250/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Weiss</surname> <given-names>Elisabeth Margarete</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Enzinger</surname> <given-names>Christian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/206404/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Pinter</surname> <given-names>Daniela</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1017182/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurology, Medical University of Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<aff id="aff2"><sup>2</sup><institution>Research Unit for Neuronal Plasticity and Repair, Department of Neurology, Medical University of Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Neuropsychology - Neuroimaging, Institute of Psychology, University of Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<aff id="aff4"><sup>4</sup><institution>Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Health Psychology, Institute of Psychology, University of Graz</institution>, <addr-line>Graz</addr-line>, <country>Austria</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Clinical Psychology, Institute of Psychology, University of Innsbruck</institution>, <addr-line>Innsbruck</addr-line>, <country>Austria</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Margit Alt Murphy, University of Gothenburg, Sweden</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Olive Lennon, University College Dublin, Ireland; Guna B&#x00113;rzi&#x00146;a, Riga Stradi&#x00146;&#x00161; University, Latvia</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Daniela Pinter <email>daniela.pinter&#x00040;medunigraz.at</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Stroke, a section of the journal Frontiers in Neurology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>791545</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Fruhwirth, Berger, Gattringer, Fandler-H&#x000F6;fler, Kneihsl, Schwerdtfeger, Weiss, Enzinger and Pinter.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Fruhwirth, Berger, Gattringer, Fandler-H&#x000F6;fler, Kneihsl, Schwerdtfeger, Weiss, Enzinger and Pinter</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> 
</permissions>
<abstract><p><bold>Background:</bold> Efficient treatment of modifiable vascular risk factors decreases reoccurrence of ischemic stroke, which is of uttermost importance in younger patients. In this longitudinal pilot study, we thus assessed the effect of a newly developed smartphone app for risk factor management in such a cohort.</p>
<p><bold>Methods:</bold> The app conveys key facts about stroke, provides motivational support for a healthy lifestyle, and a reminder function for medication intake and blood pressure measurement. Between January 2019 and February 2020, we consecutively invited patients with ischemic stroke aged between 18 and 55 years to participate. Patients in the intervention group used the app between hospital discharge and 3-month follow-up. The control group received standard clinical care. Modifiable risk factors (physical activity, nutrition, alcohol consumption, smoking behavior, obesity, and hypertension) were assessed during the initial hospital stay and at a dedicated stroke outpatient department three months post-stroke.</p>
<p><bold>Results:</bold> The study cohort comprised 21 patients in the app intervention group (62% male; age = 41 &#x000B1; 11 years; education = 12 &#x000B1; 3 years) and 21 sex-, age- and education-matched control patients with a comparable stroke risk factor profile. Baseline stroke severity was comparable between groups (intervention: <italic>median</italic> NIHSS = 3; control: <italic>median</italic> NIHSS = 4; <italic>p</italic> = 0.604). Three months post-stroke, patients in the intervention group reported to be physically almost twice as active (13 &#x000B1; 9 h/week) compared to controls (7 &#x000B1; 5 h/week; <italic>p</italic> = 0.022). More intense app usage was strongly associated with higher physical activity (<italic>r</italic> = 0.60, <italic>p</italic> = 0.005) and lower consumption of unhealthy food (<italic>r</italic> = &#x02212;0.51, <italic>p</italic> = 0.023). Smoking behavior (<italic>p</italic> = 0.001) and hypertension (<italic>p</italic> = 0.003) improved in all patients. Patients in the intervention group described better self-reported health-related quality of life three months post-stroke (<italic>p</italic> = 0.003).</p>
<p><bold>Conclusions:</bold> Specifically designed app interventions can be an easily to implement and cost-efficient approach to promote a healthier lifestyle in younger patients with a stroke.</p></abstract>
<kwd-group>
<kwd>stroke</kwd>
<kwd>secondary prevention</kwd>
<kwd>smartphone</kwd>
<kwd>app</kwd>
<kwd>risk factor management</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="50"/>
<page-count count="12"/>
<word-count count="7749"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Stroke is the leading cause of long-term disability in adults (<xref ref-type="bibr" rid="B1">1</xref>), affecting multiple domains such as cognition, motor function, and speech (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). About 10&#x02013;15% of patients with stroke are so-called young patients with stroke, i.e., aged between 18 and 50 or 55 years, and the frequency of stroke within this age range is rising (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>Most young patients with stroke have a remaining life expectancy of decades and an increased risk for recurrent stroke (<xref ref-type="bibr" rid="B6">6</xref>). Therefore, secondary stroke prevention (e.g., medication adherence and management of modifiable risk factors) is particularly crucial within this specific stroke population (<xref ref-type="bibr" rid="B7">7</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>A recent observational study in 1,730 representative patients with stroke reported an alarmingly high proportion of patients with at least one inadequately treated risk condition (up to 95% when considering vascular and lifestyle risk factors) (<xref ref-type="bibr" rid="B10">10</xref>). Analysis showed that adequate control of the five most relevant risk factors (hypertension, hypercholesterolemia, atrial fibrillation, smoking, and overweight) would have averted approximately half recurrent stroke events (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>An easily to implement and cost-efficient approach to support risk factor management, especially in younger patients with stroke might be mobile health (mHealth) (<xref ref-type="bibr" rid="B11">11</xref>&#x02013;<xref ref-type="bibr" rid="B13">13</xref>). The mHealth is defined as the use of mobile and wireless technologies, such as smartphones and tablets, to support the achievement of health objectives. In Western societies, more than 90% of adults aged between 18 and 54 years use smartphones (<xref ref-type="bibr" rid="B14">14</xref>). Due to this wide distribution among young adults and constant availability in daily routine, mHealth seems promising to support young patients with stroke in their personal risk factor self-management.</p>
<p>Although there is a huge amount of apps available supporting healthy living (e.g., fitness apps, nutrition apps, and smoking cessation apps) (<xref ref-type="bibr" rid="B15">15</xref>), surprisingly little is known regarding the benefits of such apps in stroke patient care (<xref ref-type="bibr" rid="B16">16</xref>). The few, yet promising, studies evaluating interventions by smartphone or tablet devices in patients with stroke showed improvements in vascular risk factors [arterial hypertension (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), hypercholesterolemia (<xref ref-type="bibr" rid="B19">19</xref>), diabetes mellitus (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>)] and in lifestyle factors [physical activity (<xref ref-type="bibr" rid="B21">21</xref>) and obesity (<xref ref-type="bibr" rid="B20">20</xref>)]. In addition, these studies demonstrated feasibility and showed high patient satisfaction (<xref ref-type="bibr" rid="B22">22</xref>&#x02013;<xref ref-type="bibr" rid="B25">25</xref>). However, most interventions targeted primarily either medication adherence (<xref ref-type="bibr" rid="B17">17</xref>&#x02013;<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B26">26</xref>) or motivational support for a healthy lifestyle (<xref ref-type="bibr" rid="B21">21</xref>) or stroke education (<xref ref-type="bibr" rid="B27">27</xref>), rather than providing a holistic approach. Furthermore, none of these studies investigated the benefit of nutrition apps in patients with stroke, even though unhealthy nutrition was found to be a major lifestyle risk factor for stroke (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>For this pilot study, we developed a smartphone app for secondary stroke prevention combining motivational support for a healthy lifestyle, medication adherence, and stroke education. The primary goal of this study was to investigate the effectiveness of 3 months of app usage on risk factor management in acute young patients with ischemic stroke. As secondary outcomes, we investigated clinical, cognitive, and patient-reported stroke outcomes 3 months post-stroke and patient satisfaction with the app.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec>
<title>Study Design</title>
<p>We conducted a pilot prospective study with a two group (intervention vs. control) pre-post intervention design to examine the effectiveness of a newly developed smartphone app for risk factor management in young patients with ischemic stroke. All patients received a detailed neurological examination and an extensive neuropsychological assessment during the initial stay at our department due to the acute event and at a pre-specified 3-month follow-up. Patients in the intervention group used a newly developed smartphone app for risk factor management between hospital discharge and the 3-month follow-up. Patients in the control group received no particular intervention between hospital discharge and the 3-month follow-up. Primary outcome measures were modifiable stroke risk factors (physical activity, nutrition, alcohol consumption, smoking behavior, obesity, and hypertension). Secondary outcome measures were clinical (stroke severity), cognitive, and patient-reported stroke outcomes 3 months post-stroke and patient satisfaction with the app. We conducted group comparisons between intervention and control group and evaluated the influence of the intensity of the app usage on the primary outcomes. This prospective study was approved by the ethics committee of the Medical University of Graz (permit number 29&#x02013;494 ex 16/17). All participants gave written informed consent.</p>
</sec>
<sec>
<title>Patients</title>
<p>Consecutive patients aged between 18 and 55 years admitted to the Department of Neurology at the University Hospital Graz between January 2019 and February 2020 with an acute imaging-proven ischemic stroke were invited to participate in this prospective study. Exclusion criteria were severe pre-existing cognitive impairment or higher-order brain dysfunction precluding full engagement with the study protocol, severe dysarthria, apraxia, neglect or aphasia, insufficient German language skills, and severe impairment in fine motor skills. Patients who owned a smartphone with a compatible operating system for our app (Android) and were familiar with usage of apps were assigned to the app intervention group (<xref ref-type="fig" rid="F1">Figure 1</xref>). Patients who owned a smartphone with an incompatible operating system (IOS, Windows), did not own a smartphone, did not know how to use apps, or were recruited after February 2020 (temporary app availability until February 2020) were considered as potential control patients receiving standard clinical and neuropsychological care. From all potential control patients, we created a control group that matched the intervention group regarding sex, age, education, baseline stroke severity, and stroke risk factor profile.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Recruitment process of the app intervention group between January 2019 and February 2020.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-12-791545-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Clinical and Neuropsychological Assessment</title>
<p>All patients underwent routine neurological examination [including assessment of stroke severity according to the National Institutes of Health Stroke Scale (NIHSS) score (range 0&#x02013;42 with higher values indicating greater stroke severity), and modified Rankin Scale (mRS) score (range 0&#x02013;6 with higher values indicating greater impairment)] had a vascular and lifestyle risk factor assessment and an extensive neuropsychological examination at baseline and 3 months post-stroke.</p>
<p>Experienced stroke physicians (TG, SF-H, and MK) assessed vascular risk factors according to medical history and clinical findings, including hypertension (blood pressure &#x02265; 140/90), diabetes mellitus (HbA1c &#x02265; 6.5%), dyslipidemia (low-density lipoprotein &#x02265; 100 mg/dl), atrial fibrillation, and coronary heart disease. We measured blood pressure with a standardized blood pressure monitor (MEDISANA BU 510, Neuss, Germany).</p>
<p>We assessed lifestyle risk factors during the neuropsychological examination (VF and LB) <italic>via</italic> standardized semi-structured interviews [alcohol consumption (5-point Likert scale with higher values indicating more alcohol consumption), smoking behavior (cigarettes per day), and obesity (body mass index (BMI) &#x0003E; 30)] and standardized questionnaires. Physical activity (average number of h/week) was assessed with the German questionnaire <italic>Freiburger Fragebogen zur k&#x000F6;rperlichen Aktivit&#x000E4;t</italic> (FFKA) (<xref ref-type="bibr" rid="B28">28</xref>). In the <italic>Nutrition questionnaire</italic>, patients were asked to rate on a 5-point Likert scale how often they usually consume servings of the following food groups: fruits, vegetables, legumes, whole meal foods, refined grain foods, meat, fish, dessert/sweet snacks, sugar sweetened drinks, deep fried food, dairy food, eggs, tofu/soybean curd, and alcohol. The five possible responses were: 1 = &#x0201C;never or rarely (&#x0003C;1&#x000D7;/week),&#x0201D; 2 = &#x0201C;about 1 serving each week,&#x0201D; 3 = &#x0201C;several servings each week,&#x0201D; 4 = &#x0201C;1&#x02013;2 servings each day,&#x0201D; and 5 = &#x0201C;3 or more servings each day&#x0201D; (<xref ref-type="bibr" rid="B29">29</xref>). For the interpretation of nutrition behavior, we summarized fruits, vegetables, and legumes as &#x0201C;healthy nutrition&#x0201D; and dessert/sweets, sugar-sweetened drinks, and deep-fried food as &#x0201C;unhealthy nutrition.&#x0201D; Higher scores in the category &#x0201C;healthy nutrition&#x0201D; and lower scores in the category &#x0201C;unhealthy nutrition&#x0201D; indicate a healthier eating behavior.</p>
<p>Detailed information on the cognitive test battery can be found in a previous publication (<xref ref-type="bibr" rid="B3">3</xref>). We assessed quality of life using the EuroQol Five Dimensions questionnaire (EQ-5D; ranging from 0 to 100 with higher values indicating a better self-reported health-related quality of life) (<xref ref-type="bibr" rid="B30">30</xref>). Anxiety and depression were assessed with the hospital anxiety and depression scale (HADS-D; ranging from 0 to 21, values &#x02264; 7 are considered as clinically normal) (<xref ref-type="bibr" rid="B31">31</xref>). Fine motor skills were assessed for both the dominant and non-dominant hand with the Nine-Hole Peg Test (NHPT), with longer duration times indicating worse performance (<xref ref-type="bibr" rid="B32">32</xref>).</p>
<p>In addition to the standard clinical and neuropsychological assessment, patients with stroke in the app intervention group filled out a specifically created questionnaire regarding their expectations about the helpfulness of the app in terms of life style changes at baseline and an <italic>evaluation questionnaire</italic> (e.g., amount of app usage, content-related satisfaction, comprehensibility, and navigation) 3 months post-stroke. The baseline questionnaire consisted of 12 and the evaluation questionnaire of 24 standardized questions that patients rated on a 5-point Likert scale, ranging from &#x0201C;1&#x02014;do not agree at all&#x0201D; to &#x0201C;5&#x02014;strongly agree.&#x0201D; In the evaluation questionnaire, patients were also asked how many minutes per day they used the app on average to assess the self-reported intensity of app usage.</p>
</sec>
<sec>
<title>PRESTRO: Prevent Stroke App Intervention</title>
<p>PRESTRO&#x02014;Prevent stroke is a scientifically guided smartphone app for secondary prevention after stroke, developed by a multidisciplinary team of neuropsychologists and neurologists from the Medical University Graz in cooperation with the Department of Health Psychology of Graz University and the software development company Evolaris, Graz, Austria. It was available in the <italic>Google Play Store</italic> between January 2019 and February 2020. The PRESTRO app combines motivational support for a healthy lifestyle (physical activity, healthy nutrition, and smoking cessation), a reminder function for medication intake and blood pressure measurement and stroke education in a comprehensible format (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Example screenshots from our newly developed smartphone app for secondary stroke prevention.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-12-791545-g0002.tif"/>
</fig>
<p>Based on psychological theories, such as self-efficacy expectation (<xref ref-type="bibr" rid="B33">33</xref>), action planning (<xref ref-type="bibr" rid="B34">34</xref>), reinforcement learning (<xref ref-type="bibr" rid="B35">35</xref>), building of habits (<xref ref-type="bibr" rid="B36">36</xref>), motivation (<xref ref-type="bibr" rid="B37">37</xref>), and SMART goals (<xref ref-type="bibr" rid="B38">38</xref>), we created 42 tips for each lifestyle factor: physical activity, healthy nutrition, and smoking cessation. By selecting the corresponding risk factors, patients get three tips for increasing physical activity and three tips for healthy nutrition per week <italic>via</italic> push notifications. A push notification is a message directly sent from the app that appears on the display, independent of current app or smartphone usage. This way, the app functions as a &#x0201C;personal trainer,&#x0201D; providing daily reminding, motivation, and concrete ideas how to implement healthy lifestyle in one&#x00027;s personal routine. To actively involve patients, they were asked to define personal goals regarding physical activity and healthy nutrition once a week. At the end of each week, patients were asked to evaluate the degree of goal achievement and were praised for successful completion and further encouraged when not completing their goals.</p>
<p>Furthermore, the PRESTRO app provides a virtual medicine cabinet that includes commonly prescribed antiplatelet drugs, anticoagulants, antihypertensives, cholesterol-lowering agents, and antidiabetic drugs. Patients with stroke can select their prescribed medication and get information on intake recommendation, effect of the medication, and an explanation on how the medication can help to prevent a further stroke. At individually chosen time points, patients get a reminder from the app to take their medication, which has shown to substantially improve medication adherence in patients with stroke (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B26">26</xref>). After medication intake, patients can tick off the due medication task in the app. Similarly, the app reminds patients to measure and document their systolic and diastolic blood pressure, pulse, and weight. The app displays the measured values graphically in a comprehensible format (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>The educational part of the app provides key facts about the origin and development of an ischemic stroke and its associated risk factors. Previous studies have shown that psychoeducation promotes active coping with the disease (<xref ref-type="bibr" rid="B39">39</xref>) and enhances knowledge (<xref ref-type="bibr" rid="B40">40</xref>) and self-efficacy in patients with stroke (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>Patients who fulfilled the app-intervention inclusion criteria received the login details and a detailed booklet containing information on the provided app features and navigation during their initial hospital stay. Two days after installing the app, the implementing psychologists (VF and LB) revisited the patient and made sure that the app was working correctly, and there were no further questions. Patients were instructed to use the app for 3 months.</p>
</sec>
<sec>
<title>Statistical Analyses</title>
<p>Demographics, clinical, and neuropsychological scores were analyzed with IBM SPSS Statistics 26 (IBM Corp., Armonk, NY, USA). The level of significance was set at 5%. Normal distribution was assessed with the Kolmogorov&#x02013;Smirnov test and <italic>via</italic> skewness and kurtosis. Outliers were assessed <italic>via</italic> boxplots.</p>
<p>Comparisons between the app intervention and control group were conducted with unpaired <italic>t</italic>-tests (for normally distributed continuous variables) and Mann&#x02013;Whitney <italic>U</italic>-tests (for non-normally distributed variables). Longitudinal within- and between-group comparisons were done with ANOVA. Correlation analysis was performed with Spearman (ordinal data) and Pearson (metric data) correlations.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Patient Selection and Characteristics</title>
<p>The recruitment process for the app intervention group is shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. From the initially invited 50 young patients with ischemic stroke, 60% were willing to participate in the app intervention. The main reason for not participating in the app intervention was incompatible operating systems (<italic>N</italic> = 11). Only one potential participant did not own a smartphone. The control group consisted of sex-, age- and education-matched patients with acute ischemic stroke with a comparable stroke risk factor profile who owned a smartphone with an incompatible operating system (IOS, Windows) or had technical problems (<italic>N</italic> = 9), did not own a smartphone (<italic>N</italic> = 1), did not use apps in general (<italic>N</italic> = 5), or were recruited after February 2020 (<italic>N</italic> = 6).</p>
<p>The final sample comprised 21 young patients with ischemic stroke in the app intervention group and 21 patients in the control group. At baseline, the app intervention and control group did not significantly differ regarding age, sex, education, stroke severity, post-stroke rehabilitation therapy, stroke risk factors, and fine motor skills (<xref ref-type="table" rid="T1">Table 1</xref>). The most prevalent stroke risk factors were hypertension, hyperlipidemia, and smoking. The mRS at discharge was slightly higher in the control group compared to the intervention group. In addition, patients in the control group had higher anxiety scores and performed worse in the cognitive screening. However, there were no significant group differences in all other cognitive tasks. Regarding stroke severity, cognition, and fine motor skills, successful smartphone usage would have been possible in all included patients.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Demographics, clinical, and neuropsychological characteristics of young ischemic stroke patients in the app intervention group and control group at stroke onset.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="center"><bold>App intervention group <italic>N</italic> = 21</bold></th>
<th valign="top" align="center"><bold>Control group <italic>N</italic> = 21</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Demographics</bold></td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Age in years, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic></td>
<td valign="top" align="center">41 (11); 45 (30&#x02013;50); 20&#x02013;55</td>
<td valign="top" align="center">47 (8); 50 (44&#x02013;53); 25&#x02013;54</td>
<td valign="top" align="center">0.056</td>
</tr>
<tr>
<td valign="top" align="left">Sex, female, <italic>N</italic> (%)</td>
<td valign="top" align="center">8 (38.1)</td>
<td valign="top" align="center">9 (42.9)</td>
<td valign="top" align="center">0.760</td>
</tr>
<tr>
<td valign="top" align="left">Education in years, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic></td>
<td valign="top" align="center">12 (3); 11 (10&#x02013;14); 9&#x02013;19</td>
<td valign="top" align="center">11 (3); 10 (10&#x02013;13); 8&#x02013;18</td>
<td valign="top" align="center">0.341</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Clinical characteristics</bold></td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">NIHSS, <italic>median</italic> (<italic>IQR</italic>)</td>
<td valign="top" align="center">3 (1&#x02013;6)</td>
<td valign="top" align="center">4 (1&#x02013;7)</td>
<td valign="top" align="center">0.604</td>
</tr>
<tr>
<td valign="top" align="left">mRS at discharge, <italic>median</italic> (<italic>IQR</italic>)</td>
<td valign="top" align="center">1 (0&#x02013;2)</td>
<td valign="top" align="center">2 (1&#x02013;2)</td>
<td valign="top" align="center"><bold>0.008</bold></td>
</tr>
<tr>
<td valign="top" align="left">Rehabilitation therapy after discharge, <italic>N</italic> (%)</td>
<td valign="top" align="center">10 (47.6)</td>
<td valign="top" align="center">13 (61.9)</td>
<td valign="top" align="center">0.365</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Vascular risk factors</bold></td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Hypertension, <italic>N</italic> (%)</td>
<td valign="top" align="center">8 (38.1)</td>
<td valign="top" align="center">8 (38.1)</td>
<td valign="top" align="center">0.999</td>
</tr>
<tr>
<td valign="top" align="left">Systolic blood pressure, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">139 (19); 133 (123&#x02013;156); 115&#x02013;190</td>
<td valign="top" align="center">140 (22); 141 (128&#x02013;156); 100&#x02013;190</td>
<td valign="top" align="center">0.855</td>
</tr>
<tr>
<td valign="top" align="left">Diastolic blood pressure, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">87 (11); 88 (79&#x02013;96); 70&#x02013;108</td>
<td valign="top" align="center">83 (13); 83 (73&#x02013;93); 58&#x02013;107</td>
<td valign="top" align="center">0.236</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus, <italic>N</italic> (%)</td>
<td valign="top" align="center">0 (0)</td>
<td valign="top" align="center">2 (9.5)</td>
<td valign="top" align="center">0.162</td>
</tr>
<tr>
<td valign="top" align="left">Hyperlipidemia, <italic>N</italic> (%)</td>
<td valign="top" align="center">9 (42.9)</td>
<td valign="top" align="center">5 (23.8)</td>
<td valign="top" align="center">0.200</td>
</tr>
<tr>
<td valign="top" align="left">Atrial fibrillation, <italic>N</italic> (%)</td>
<td valign="top" align="center">1 (4.8)</td>
<td valign="top" align="center">0 (0)</td>
<td valign="top" align="center">0.329</td>
</tr>
<tr>
<td valign="top" align="left">Coronary heart disease, <italic>N</italic> (%)</td>
<td valign="top" align="center">0 (0)</td>
<td valign="top" align="center">1 (4.8)</td>
<td valign="top" align="center">0.329</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Lifestyle and psychological risk factors</bold></td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Active smoking, <italic>N</italic> (%)</td>
<td valign="top" align="center">6 (28.6)</td>
<td valign="top" align="center">8 (38.1)</td>
<td valign="top" align="center">0.524</td>
</tr>
<tr>
<td valign="top" align="left">Clinically diagnosed alcohol abuse (ICD-10 criterion F10.2), <italic>N</italic> (%)</td>
<td valign="top" align="center">3 (14.3)</td>
<td valign="top" align="center">1 (4.8)</td>
<td valign="top" align="center">0.306</td>
</tr>
<tr>
<td valign="top" align="left">Self-reported alcohol consumption, <italic>mean</italic> (SD); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN2"><sup>&#x0002A;&#x0002A;</sup></xref></td>
<td valign="top" align="center">1.9 (1.0); 2.0 (1.0&#x02013;2.0); 1&#x02013;4</td>
<td valign="top" align="center">1.5 (0.8); 1.0 (1.0&#x02013;2.0); 1&#x02013;3</td>
<td valign="top" align="center">0.160</td>
</tr>
<tr>
<td valign="top" align="left">Weight in kg, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic></td>
<td valign="top" align="center">84 (16); 84 (70&#x02013;100); 55&#x02013;110</td>
<td valign="top" align="center">80 (14); 82 (69&#x02013;90); 56&#x02013;105</td>
<td valign="top" align="center">0.497</td>
</tr>
<tr>
<td valign="top" align="left">BMI, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic></td>
<td valign="top" align="center">28 (5); 27 (24&#x02013;32); 19&#x02013;34</td>
<td valign="top" align="center">27 (3); 27 (24&#x02013;29); 23&#x02013;32</td>
<td valign="top" align="center">0.499</td>
</tr>
<tr>
<td valign="top" align="left">Physical activity in h/week, <italic>mean</italic> (SD); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic></td>
<td valign="top" align="center">7 (6); 6 (2&#x02013;11); 0&#x02013;24</td>
<td valign="top" align="center">5 (4); 4 (2&#x02013;7); 0&#x02013;17</td>
<td valign="top" align="center">0.272</td>
</tr>
<tr>
<td valign="top" align="left">Self-reported healthy nutrition, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN3"><sup>&#x0002A;&#x0002A;&#x0002A;</sup></xref></td>
<td valign="top" align="center">2.7 (0.7); 2.7 (2.2&#x02013;3.2); 1&#x02013;4</td>
<td valign="top" align="center">2.8 (0.7); 3.0 (2.5&#x02013;3.1); 1&#x02013;4</td>
<td valign="top" align="center">0.526</td>
</tr>
<tr>
<td valign="top" align="left">Self-reported unhealthy nutrition, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN3"><sup>&#x0002A;&#x0002A;&#x0002A;</sup></xref></td>
<td valign="top" align="center">2.5 (0.7); 2.7 (2.0&#x02013;3.0); 1&#x02013;4</td>
<td valign="top" align="center">2.5 (0.5); 2.7 (2.2&#x02013;2.8); 1&#x02013;3</td>
<td valign="top" align="center">0.865</td>
</tr>
<tr>
<td valign="top" align="left">HADS-D Depression, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">3 (4); 2 (1&#x02013;5); 0&#x02013;12</td>
<td valign="top" align="center">5 (3); 5 (2&#x02013;8); 0&#x02013;12</td>
<td valign="top" align="center">0.176</td>
</tr>
<tr>
<td valign="top" align="left">HADS-D Anxiety, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">5 (3); 4 (3&#x02013;7); 1&#x02013;13</td>
<td valign="top" align="center">8 (3); 8 (5&#x02013;10); 1&#x02013;15</td>
<td valign="top" align="center"><bold>0.014</bold></td>
</tr>
<tr>
<td valign="top" align="left"><bold>Medication</bold>, <italic><bold>N</bold></italic> <bold>(%)</bold></td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">Antiplatelets</td>
<td valign="top" align="center">18 (85.7)</td>
<td valign="top" align="center">17 (81.0)</td>
<td valign="top" align="center">0.688</td>
</tr>
<tr>
<td valign="top" align="left">Anticoagulants</td>
<td valign="top" align="center">2 (9.5)</td>
<td valign="top" align="center">4 (19.0)</td>
<td valign="top" align="center">0.390</td>
</tr>
<tr>
<td valign="top" align="left">Antihypertensives</td>
<td valign="top" align="center">8 (38.1)</td>
<td valign="top" align="center">8 (38.1)</td>
<td valign="top" align="center">0.999</td>
</tr>
<tr>
<td valign="top" align="left">Cholesterol-lowering</td>
<td valign="top" align="center">11 (52.4)</td>
<td valign="top" align="center">10 (47.6)</td>
<td valign="top" align="center">0.765</td>
</tr>
<tr>
<td valign="top" align="left">Antidiabetics</td>
<td valign="top" align="center">0 (0.0)</td>
<td valign="top" align="center">1 (4.8)</td>
<td valign="top" align="center">0.329</td>
</tr>
<tr>
<td valign="top" align="left">Antidepressants</td>
<td valign="top" align="center">3 (14.3)</td>
<td valign="top" align="center">7 (33.3)</td>
<td valign="top" align="center">0.155</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Neuropsychological assessment</bold>, <italic><bold>mean</bold></italic> <bold>(</bold><italic><bold>SD</bold></italic><bold>);</bold> <italic><bold>median</bold></italic> <bold>(</bold><italic><bold>IQR</bold></italic><bold>);</bold> <italic><bold>min</bold></italic>&#x02013;<italic><bold>max</bold></italic></td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">EQ-5D self-reported quality of life</td>
<td valign="top" align="center">70 (18); 70 (53&#x02013;88); 33&#x02013;99</td>
<td valign="top" align="center">59 (25); 50 (40&#x02013;83); 0&#x02013;100</td>
<td valign="top" align="center">0.097</td>
</tr>
<tr>
<td valign="top" align="left">MoCA (raw score)</td>
<td valign="top" align="center">28 (2); 29 (28&#x02013;30); 25&#x02013;30</td>
<td valign="top" align="center">25 (5); 27 (21&#x02013;28); 13&#x02013;30</td>
<td valign="top" align="center"><bold>0.003</bold></td>
</tr>
<tr>
<td valign="top" align="left">SDMT (z-norm)</td>
<td valign="top" align="center">&#x02212;1.0 (1.2); &#x02212;1.0 (&#x02212;1.8&#x02013;(&#x02212;0.5)); &#x02212;3.0&#x02013;1.5</td>
<td valign="top" align="center">&#x02212;1.5 (1.4); &#x02212;1.5 (&#x02212;3.0&#x02013;0.0); &#x02212;3.0&#x02013;1.5</td>
<td valign="top" align="center">0.233</td>
</tr>
<tr>
<td valign="top" align="left">CTMT-2 (t-norm)<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">44 (10); 43 (36&#x02013;54); 26&#x02013;61</td>
<td valign="top" align="center">40 (14); 39 (31&#x02013;50); 18&#x02013;72</td>
<td valign="top" align="center">0.334</td>
</tr>
<tr>
<td valign="top" align="left">CTMT-5 (t-norm)<xref ref-type="table-fn" rid="TN4"><sup>&#x02020;</sup></xref></td>
<td valign="top" align="center">39 (10); 39 (30&#x02013;46); 22&#x02013;61</td>
<td valign="top" align="center">37 (16); 37 (25&#x02013;48); 18&#x02013;68</td>
<td valign="top" align="center">0.744</td>
</tr>
<tr>
<td valign="top" align="left">NHPT in seconds (dominant hand<xref ref-type="table-fn" rid="TN5"><sup>&#x02021;</sup></xref></td>
<td valign="top" align="center">25 (8); 22 (20&#x02013;27); 19&#x02013;42</td>
<td valign="top" align="center">25 (7); 23 (20&#x02013;28); 15&#x02013;45</td>
<td valign="top" align="center">0.832</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>N, sample size; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; EQ-5D, EuroQol Five Dimensions (health-related quality of life); HADS-D, hospital anxiety and depression scale; MoCA, Montreal Cognitive Assessment (cognitive screening); SDMT, Symbol Digital Modalities Test (processing speed); CTMT, Comprehensive Trail Making Test (subtest 2: attention, subtest 5: cognitive flexibility); NHPT, Nine-Hole Peg Test (fine motor skills);</italic></p> 
<fn id="TN1">
<label>&#x0002A;</label>
<p><italic>missing in one patient;</italic></p></fn> 
<fn id="TN2">
<label>&#x0002A;&#x0002A;</label>
<p><italic>Self-rating on a 5-point Likert scale (1&#x02013;5) where higher values indicate more alcohol consumption;</italic></p></fn> 
<fn id="TN3">
<label>&#x0002A;&#x0002A;&#x0002A;</label>
<p><italic>higher scores in &#x0201C;healthy nutrition&#x0201D; and lower scores in &#x0201C;unhealthy nutrition&#x0201D; indicate a healthier eating behavior;</italic></p></fn> 
<fn id="TN4">
<label>&#x02020;</label>
<p><italic>missing in two patients;</italic></p></fn> 
<fn id="TN5">
<label>&#x02021;</label>
<p><italic>missing in three patients. Bold values indicate significant p-values</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Primary Outcome: Beneficial Effect of the PRESTO App on Stroke Risk Factor Management</title>
<p>The primary outcome measures (physical activity, nutrition, alcohol consumption, smoking behavior, obesity, and hypertension) are presented for the intervention and control group 3 months post-stroke in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Primary outcome: Modifiable stroke risk factors for the intervention and control group 3 months post-stroke.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="center"><bold>App intervention group <italic>N</italic> = 21</bold></th>
<th valign="top" align="center"><bold>Control group <italic>N</italic> = 21</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value</bold></th>
<th valign="top" align="center"><bold><italic>Cohen&#x00027;s d</italic></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Physical activity in h/week, <italic>mean</italic> (SD); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN6"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">13 (9); 11 (8&#x02013;17); 0&#x02013;41</td>
<td valign="top" align="center">7 (5); 8 (4&#x02212;10); 0&#x02013;16</td>
<td valign="top" align="center"><bold>0.022</bold></td>
<td valign="top" align="center"><bold>0.7</bold></td>
</tr>
<tr>
<td valign="top" align="left">Self-reported healthy nutrition, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN8"><sup>&#x02020;</sup></xref><xref ref-type="table-fn" rid="TN7"><sup>&#x0002A;&#x0002A;&#x0002A;</sup></xref></td>
<td valign="top" align="center">3.2 (0.6); 3.3 (3.0&#x02013;3.5); 1&#x02013;4</td>
<td valign="top" align="center">3.2 (0.5); 3.0 (3.0&#x02013;3.7); 2&#x02013;4</td>
<td valign="top" align="center">0.996</td>
<td valign="top" align="center">0.0</td>
</tr>
<tr>
<td valign="top" align="left">Self-reported unhealthy nutrition, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN6"><sup>&#x0002A;</sup></xref><xref ref-type="table-fn" rid="TN7"><sup>&#x0002A;&#x0002A;&#x0002A;</sup></xref></td>
<td valign="top" align="center">2.0 (0.7); 2.0 (1.5&#x02013;2.3); 1&#x02013;4</td>
<td valign="top" align="center">2.0 (0.4); 2.0 (1.8&#x02013;2.3); 1&#x02013;3</td>
<td valign="top" align="center">0.855</td>
<td valign="top" align="center">0.1</td>
</tr>
<tr>
<td valign="top" align="left">Self-reported alcohol consumption, <italic>mean</italic> (SD); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN7"><sup>&#x0002A;&#x0002A;&#x0002A;</sup></xref></td>
<td valign="top" align="center">1.6 (0.7); 1.0 (1.0&#x02013;2.0); 1&#x02013;3</td>
<td valign="top" align="center">1.2 (0.4); 1.0 (1.0&#x02013;1.0); 1&#x02013;2</td>
<td valign="top" align="center"><bold>0.015</bold></td>
<td valign="top" align="center"><bold>0.8</bold></td>
</tr>
<tr>
<td valign="top" align="left">Active smoking, <italic>N</italic> (%)</td>
<td valign="top" align="center">1 (4.8)</td>
<td valign="top" align="center">2 (9.5)</td>
<td valign="top" align="center">0.560</td>
<td valign="top" align="center">0.2</td>
</tr>
<tr>
<td valign="top" align="left">Systolic blood pressure, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN8"><sup>&#x02020;</sup></xref></td>
<td valign="top" align="center">128 (11); 130 (120&#x02013;137); 101&#x02013;148</td>
<td valign="top" align="center">128 (16); 129 (115&#x02013;140); 99&#x02013;159</td>
<td valign="top" align="center">0.875</td>
<td valign="top" align="center">0.1</td>
</tr>
<tr>
<td valign="top" align="left">Diastolic blood pressure, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN8"><sup>&#x02020;</sup></xref></td>
<td valign="top" align="center">85 (14); 83 (78&#x02013;93); 56&#x02013;113</td>
<td valign="top" align="center">82 (9); 82 (72&#x02013;88); 69&#x02013;104</td>
<td valign="top" align="center">0.481</td>
<td valign="top" align="center">0.2</td>
</tr>
<tr>
<td valign="top" align="left">Weight in kg, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN8"><sup>&#x02020;</sup></xref></td>
<td valign="top" align="center">81 (16); 81 (68&#x02013;93); 55&#x02013;111</td>
<td valign="top" align="center">80 (13); 81 (69&#x02013;92); 59&#x02013;105</td>
<td valign="top" align="center">0.832</td>
<td valign="top" align="center">0.1</td>
</tr>
<tr>
<td valign="top" align="left">BMI, <italic>mean</italic> (<italic>SD</italic>); <italic>median</italic> (<italic>IQR</italic>); <italic>min</italic>&#x02013;<italic>max</italic><xref ref-type="table-fn" rid="TN8"><sup>&#x02020;</sup></xref></td>
<td valign="top" align="center">27 (5); 27 (23&#x02013;32); 19&#x02013;35</td>
<td valign="top" align="center">27 (3); 26 (25&#x02013;30); 22&#x02013;32</td>
<td valign="top" align="center">0.893</td>
<td valign="top" align="center">0.0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>N, sample size; IQR, interquartile range; BMI, body mass index</italic>.</p> 
<fn id="TN6">
<label>&#x0002A;</label>
<p><italic>missing in one patient;</italic></p></fn> 
<p><italic>&#x0002A;&#x0002A; Self-rating on a 5-point Likert scale (1&#x02013;5) where higher values indicate more alcohol consumption;</italic></p>
<fn id="TN7">
<label>&#x0002A;&#x0002A;&#x0002A;</label>
<p><italic>higher scores in &#x0201C;healthy nutrition&#x0201D; and lower scores in &#x0201C;unhealthy nutrition&#x0201D; indicate a healthier eating behavior;</italic></p></fn> 
<fn id="TN8">
<label>&#x02020;</label>
<p><italic>missing in two patients. Bold values indicate significant p-values</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Physical Activity</title>
<p>Baseline self-reported physical activity was comparable between the app intervention (7 &#x000B1; 6 h/week) and the control group (5 &#x000B1; 4 h/week; <italic>p</italic> = 0.272). However, 3 months post-stroke, app users were physically almost twice as active (13 &#x000B1; 9 h/week) compared to controls (7 &#x000B1; 5 h/week; <italic>p</italic> = 0.022). Within the app intervention group, a more intense app usage was strongly associated with higher physical activity (<italic>r</italic> = 0.60, <italic>p</italic> = 0.005). Physical activity 3 months post-stroke was neither associated with mRS at discharge (<italic>p</italic> = 0.311) nor with mRS 3 months post-stroke (<italic>p</italic> = 0.109). In one patient with mRS = 4 (control group), physical activity was not assessed at follow-up and therefore not included in the analyses.</p>
</sec>
<sec>
<title>Nutrition</title>
<p>All young patients with ischemic stroke improved their nutrition 3 months post-stroke independent of app-usage. ANOVAs revealed an increase in self-reported healthy nutrition (<italic>p</italic> &#x0003C; 0.001) and a decrease in self-reported unhealthy nutrition (<italic>p</italic> &#x0003C; 0.001). However, considering the intensity of the app usage in the app intervention group, we found a strong association between more intense app usage and lower consumption of unhealthy food 3 months post-stroke (<italic>r</italic> = &#x02212;0.51, <italic>p</italic> = 0.023).</p>
</sec>
<sec>
<title>Alcohol Consumption</title>
<p>Self-reported alcohol consumption decreased in all young patients with ischemic stroke 3 months post-stroke (<italic>p</italic> = 0.041). However, patients in the app intervention group reported to consume more alcohol than patients in the control group 3 months post-stroke (<italic>p</italic> = 0.015).</p>
</sec>
<sec>
<title>Smoking Behavior</title>
<p>Smoking behavior also improved in all young patients with ischemic stroke 3 months post-stroke (<italic>p</italic> = 0.001). At baseline, six young patients with ischemic stroke in the app intervention group and eight patients in the control group smoked. Three-months post-stroke, only one patient in the app intervention group and two patients in the control group did not quit smoking.</p>
</sec>
<sec>
<title>Obesity and Hypertension</title>
<p>Mean systolic blood pressure (intervention: <italic>p</italic> = 0.003; control: <italic>p</italic> = 0.033) improved in all young patients with ischemic stroke independent of app usage 3 months post-stroke. Mean diastolic blood pressure (intervention: <italic>p</italic> = 0.396; control: <italic>p</italic> = 0.692), weight (intervention: <italic>p</italic> = 0.131; control: <italic>p</italic> = 0.983), and BMI (intervention: <italic>p</italic> = 0.127; control: <italic>p</italic> = 0.833) did not change within 3 months post-stroke.</p>
<p>When correcting for baseline group differences in the Montreal Cognitive Assessment (MoCA), anxiety, and mRS at discharge, the group difference in the self-reported alcohol consumption 3 months post-stroke is no longer significant (<italic>p</italic> = 0.222). All other primary results remain stable.</p>
</sec>
<sec>
<title>Secondary Outcome 1: Clinical, Cognitive, and Patient-Reported Stroke Outcome</title>
<p>Clinical and neuropsychological characteristics 3 months post-stroke are presented in <xref ref-type="table" rid="T3">Table 3</xref> (baseline characteristics in <xref ref-type="table" rid="T1">Table 1</xref>). Baseline stroke severity (NIHSS) was comparable between young patients with ischemic stroke in the app intervention group and control patients. However, 3 months post-stroke, the degree of disability or dependence in daily activities (mRS) in the app intervention group was significantly lower than in the control group. Similar, self-reported quality of life was higher in the app intervention group than in the control group 3 months post-stroke, despite comparable baseline values. Interestingly, participating in the app intervention group was associated with better self-reported quality of life 3 months post-stroke independent of baseline stroke severity (<italic>p</italic> = 0.003). Cognitive flexibility was higher in the app intervention group 3 months post-stroke than in the control group, despite comparable baseline performance (<italic>p</italic> = 0.039).</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Secondary outcome: Clinical and neuropsychological characteristics of young patients with ischemic stroke in the app intervention group and control group 3 months post-stroke.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="center"><bold>App intervention group <italic>N</italic> = 21</bold></th>
<th valign="top" align="center"><bold>Control group <italic>N</italic> = 21</bold></th>
<th valign="top" align="center"><bold><italic>P</italic>-value</bold></th>
<th valign="top" align="center"><bold><italic>Cohen&#x00027;s d</italic></bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Clinical characteristics</bold>, <italic><bold>median</bold></italic> <bold>(</bold><italic><bold>IQR</bold></italic><bold>)</bold></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">NIHSS</td>
<td valign="top" align="center">0 (0&#x02013;0)</td>
<td valign="top" align="center">1 (0&#x02013;2)</td>
<td valign="top" align="center"><bold>0.005</bold></td>
<td valign="top" align="center"><bold>0.9</bold></td>
</tr>
<tr>
<td valign="top" align="left">mRS</td>
<td valign="top" align="center">0 (0&#x02013;1)</td>
<td valign="top" align="center">2 (1-2)</td>
<td valign="top" align="center"><bold>0.008</bold></td>
<td valign="top" align="center"><bold>0.9</bold></td>
</tr>
<tr>
<td valign="top" align="left"><bold>Neuropsychological assessment</bold>, <italic><bold>mean</bold></italic> <bold>(</bold><italic><bold>SD</bold></italic><bold>);</bold> <italic><bold>median</bold></italic> <bold>(</bold><italic><bold>IQR</bold></italic><bold>);</bold> <italic><bold>min</bold></italic>&#x02013;<italic><bold>max</bold></italic></td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">EQ-5D self-reported quality of life<xref ref-type="table-fn" rid="TN9"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">84 (15); 90 (73&#x02013;95); 50-100</td>
<td valign="top" align="center">72 (17); 77 (60-80); 30-100</td>
<td valign="top" align="center"><bold>0.030</bold></td>
<td valign="top" align="center"><bold>0.7</bold></td>
</tr>
<tr>
<td valign="top" align="left">HADS-D Depression<xref ref-type="table-fn" rid="TN9"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">2 (2); 1 (0&#x02013;2); 0&#x02013;7</td>
<td valign="top" align="center">3 (4); 2 (1&#x02013;6); 0-13</td>
<td valign="top" align="center">0.066</td>
<td valign="top" align="center">0.6</td>
</tr>
<tr>
<td valign="top" align="left">HADS-D Anxiety<xref ref-type="table-fn" rid="TN9"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">3 (3); 3 (1&#x02013;5); 0&#x02013;12</td>
<td valign="top" align="center">5 (3); 6 (3&#x02013;8); 0&#x02013;12</td>
<td valign="top" align="center"><bold>0.041</bold></td>
<td valign="top" align="center"><bold>0.7</bold></td>
</tr>
<tr>
<td valign="top" align="left">MoCA (raw score)</td>
<td valign="top" align="center">29 (2); 29 (28&#x02013;30); 24&#x02013;30</td>
<td valign="top" align="center">27 (3); 29 (26&#x02013;29); 20&#x02013;30</td>
<td valign="top" align="center">0.122</td>
<td valign="top" align="center">0.5</td>
</tr>
<tr>
<td valign="top" align="left">SDMT (z-norm)</td>
<td valign="top" align="center">&#x02212;0.1 (1.0); &#x02212;0.3 (&#x02212;0.5&#x02013;0.5); &#x02212;2.0&#x02013;2.0</td>
<td valign="top" align="center">&#x02212;0.7 (1.2); &#x02212;0.5 (&#x02212;1.7&#x02013;0.5); &#x02212;2.8&#x02013;1.5</td>
<td valign="top" align="center">0.075</td>
<td valign="top" align="center">0.6</td>
</tr>
<tr>
<td valign="top" align="left">CTMT-2 (t-norm)</td>
<td valign="top" align="center">52 (12); 54 (42&#x02013;60); 36&#x02013;76</td>
<td valign="top" align="center">44 (17); 41 (36&#x02013;48); 18&#x02013;85</td>
<td valign="top" align="center">0.088</td>
<td valign="top" align="center">0.5</td>
</tr>
<tr>
<td valign="top" align="left">CTMT-5 (t-norm)</td>
<td valign="top" align="center">49 (11); 46 (43&#x02013;56); 36&#x02013;83</td>
<td valign="top" align="center">40 (15); 41 (28&#x02013;49); 18&#x02013;71</td>
<td valign="top" align="center"><bold>0.039</bold></td>
<td valign="top" align="center"><bold>0.7</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>N, sample size; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; SD, Standard deviation; EQ-5D, EuroQol Five Dimensions (health-related quality of life); HADS-D, Hospital anxiety and depression scale; MoCA, Montreal Cognitive Assessment (cognitive screening); SDMT, Symbol Digital Modalities Test (processing speed); CTMT, Comprehensive Trail Making Test (subtest 2: attention, subtest 5: cognitive flexibility)</italic>.</p> 
<fn id="TN9">
<label>&#x0002A;</label>
<p><italic>missing in one patient. Bold values indicate significant p-values</italic>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>When correcting for baseline group differences in the MoCA, anxiety, and mRS at discharge, the group differences in the NIHSS (<italic>p</italic> = 0.411), mRS (<italic>p</italic> = 0.942), self-reported health-related quality of life (<italic>p</italic> = 0.920), anxiety (<italic>p</italic> = 0.278), and cognitive flexibility (<italic>p</italic> = 0.878) 3 months post-stroke are no longer significant.</p>
</sec>
<sec>
<title>Secondary Outcome 2: Patient Satisfaction With the PRESTRO App</title>
<p>Patient satisfaction with the PRESTRO app was high. About 90% of young patients with ischemic stroke in the app intervention group reported &#x0201C;high&#x0201D; or &#x0201C;very high&#x0201D; overall satisfaction regarding motivational support for healthy lifestyle, reminder function for medication intake and blood pressure measurement, and stroke education. All young patients with ischemic stroke in the intervention group rated the app as easy to operate.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this pilot study, we developed and preliminary evaluated a smartphone app for secondary stroke prevention combining motivational support for a healthy lifestyle (physical activity, healthy nutrition, and smoking cessation), medication adherence, and stroke education. We evaluated the effectiveness of the app on stroke risk factor management, clinical, cognitive, and patient-reported stroke outcome 3 months post-stroke and patient satisfaction with the app in young patients with ischemic stroke. App users profited from motivational support provided by the app resulting in increased physical activity. Post-stroke disability was lower and self-reported quality of life was higher in the app intervention than in the control group 3 months after stroke. Furthermore, the majority of app users were highly satisfied with our newly developed smartphone app in terms of content and usage.</p>
<p>Regarding risk factor management, our smartphone app seemed to have helped young patients with ischemic stroke to promote a healthy lifestyle. Three months post-stroke, app users were physically almost twice as active compared to patients in the control group. This result is in line with a previous study (<xref ref-type="bibr" rid="B21">21</xref>) that demonstrated the positive effect of an app that incorporates evidence-based behavior change techniques (feedback, self-monitoring, and social support) on physical activity in patients with stroke. Furthermore, we found an association between more intense app usage and better eating habits 3 months post-stroke. Physical activity and nutrition are two crucial modifiable risk factors of stroke (<xref ref-type="bibr" rid="B7">7</xref>) and are strongly associated with other stroke risk factors such as obesity, diabetes mellitus, hyperlipidemia, and hypertension (<xref ref-type="bibr" rid="B43">43</xref>). Therefore, changing lifestyle is crucial to prevent further strokes and can be supported by an app intervention.</p>
<p>Despite increased physical activity and better eating habits, we found no significant improvement in weight or BMI 3 months post-stroke. A possible explanation might be the short duration of only 3 months app usage in our study. A study that conducted an app intervention in patients with stroke for 6 months found significant improvements in BMI and waist circumference (<xref ref-type="bibr" rid="B20">20</xref>), whereas a different study that conducted an app intervention for only 6 weeks also found no changes in BMI (<xref ref-type="bibr" rid="B21">21</xref>). A longer follow-up time (and a larger study sample) might be necessary to find significant changes in more resistant measures such as weight or BMI.</p>
<p>Studies that investigated the effect of app interventions on blood pressure measurement in patients with stroke showed inconclusive results. Some report stronger improvements in the intervention than the control group (<xref ref-type="bibr" rid="B18">18</xref>), whereas others found no such differences (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B26">26</xref>). In our study, all young patients with ischemic stroke significantly improved in systolic blood pressure independent of app usage. However, app users reported that the reminder function for blood pressure measurement was very helpful to keep track of their personal blood pressure values. Moreover, they experienced the motivational support for smoking cessation as very helpful, yet all young patients with ischemic stroke improved their smoking behavior 3 months post-stroke.</p>
<p>Interestingly, in addition to the beneficial effect of the app on healthy lifestyle, we found that participating in the app intervention was associated with better self-reported quality of life 3 months post-stroke independent from baseline stroke severity. The app aims to empower young patients with ischemic stroke to actively cope with the changes following stroke. By giving specific lifestyle and risk factor management advice, patients can actively prevent a further stroke. This might help patients to improve the resilience and self-efficacy of patients (<xref ref-type="bibr" rid="B44">44</xref>). Recent studies showed an association between higher psychological resilience and better long-term stroke outcome (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Active coping promoted by the app could improve the resilience of patients, which could lead to higher rehabilitation motivation and furthermore to better subjective health status and lower stroke severity 3 months post-stroke.</p>
<p>In line with a previous study demonstrating that an app intervention can improve the knowledge of patients on stroke risk factors (<xref ref-type="bibr" rid="B27">27</xref>), our app focuses on comprehensible stroke education. It provides key facts about the origin and development of an ischemic stroke, its associated risk factors, and ways to diminish those risk factors. Although such stroke education is part of the standard care during the initial stay, the flood of information regarding for example the disease itself, newly prescribed medication, results of additional medical examinations, and rehabilitation approaches might be quite overwhelming. This may be especially so during the acute stage, when vigilance might be reduced (<xref ref-type="bibr" rid="B47">47</xref>), and cognitive deficits are frequently present (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Young patients with ischemic stroke experienced the summary of the most important stroke facts provided by our app as helpful after hospital discharge.</p>
<p>Our study does not come without limitations. The main limitation of our study was that our patients were not randomly allocated to the intervention and control groups. Similar to a previous study (<xref ref-type="bibr" rid="B19">19</xref>), our app was only available for Android-operated devices, and therefore, in line with this study, we decided to use patients with different operating systems as control group. However, the vast majority of smartphone owners with a different operating system reported that they would have used the app if possible. Furthermore, it is important to notice that the lifestyle risk factors (physical activity, nutrition, and smoking behavior) were assessed <italic>via</italic> questionnaires and therefore might be biased due to social desirability. However, we compared an intervention and control group that were both examined with the same questionnaires, and therefore social desirability should have similar effects on response tendencies among groups. Furthermore, previous studies (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>) showed moderate to strong correlations between self-reported lifestyle behavior and objectively measured lifestyle behavior. In addition, despite good matching in many relevant baseline characteristics, our groups differed at baseline in the MoCA score, anxiety, and mRS at discharge. When including these variables in the analyses as covariates, the secondary outcomes are no longer significant. However, this might also be due to a statistical overfitting in a rather small sample and should be further explored in a larger sample. Furthermore, we included no intervention regarding the lifestyle risk factor alcohol, which is a known risk factor for recurrent events. We explained this risk factor in the information part of the app, highlighting that patients with an alcohol addiction need professional treatment that is difficult to provide <italic>via</italic> app. In addition, the sample size of this pilot study was limited, and larger (multicenter) cohorts will be necessary to further explore the beneficial effects of smartphone apps on risk factor management in patients with stroke. In further studies comprising a larger cohort, it would also be important to analyze dropout patients (i.e., intention to treat analysis) to identify baseline characteristics that possibly enhance the risk of poor compliance. Nevertheless, our study shows promising results regarding lifestyle improvement, stroke outcome, and patient satisfaction that are in line with previous studies (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B20">20</xref>&#x02013;<xref ref-type="bibr" rid="B25">25</xref>).</p>
</sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusion</title>
<p>In conclusion, young patients with ischemic stroke, especially benefited from motivational support leading to increased physical activity. Furthermore, we found that participating in the app intervention was associated with better self-reported quality of life 3 months post-stroke independent of baseline stroke severity. This suggests enormous potential for such specifically designed app interventions, complementing personal clinical care.</p>
</sec>
<sec sec-type="data-availability" id="s6">
<title>Data Availability Statement</title>
<p>Data that support the findings of this study are available from the corresponding author upon reasonable request.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>This study involved human participants and was reviewed and approved by the Ethics Committee of the Medical University of Graz (permit number 29-494 ex 16/17). The patients provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>VF, DP, LB, TG, SF-H, and MK: data collection. VF, DP, and LB: material preparation and analysis. VF: first draft of the manuscript. All authors commented on previous versions of the manuscript, read, approved the final manuscript, design, and contributed to the study conception.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This study was funded by the Styrian Government, Austria (Das Land Steiermark) (ABT08-119893/2017).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec> 
</body>
<back>
<ack><p>We thank the doctoral program Sustainable Health Research of the Medical University of Graz for covering the publication costs.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grefkes</surname> <given-names>C</given-names></name> <name><surname>Fink</surname> <given-names>GR</given-names></name></person-group>. <article-title>Recovery from stroke: current concepts and future perspectives</article-title>. <source>Neurol Res Pract.</source> (<year>2020</year>) <volume>2</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.1186/s42466-020-00060-6</pub-id><pub-id pub-id-type="pmid">33324923</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goeggel Simonetti</surname> <given-names>B</given-names></name> <name><surname>Mono</surname> <given-names>M-L</given-names></name> <name><surname>Huynh-Do</surname> <given-names>U</given-names></name> <name><surname>Michel</surname> <given-names>P</given-names></name> <name><surname>Odier</surname> <given-names>C</given-names></name> <name><surname>Sztajzel</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS)</article-title>. <source>J Neurol.</source> (<year>2015</year>) <volume>262</volume>:<fpage>2025</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-015-7805-5</pub-id><pub-id pub-id-type="pmid">26668078</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinter</surname> <given-names>D</given-names></name> <name><surname>Enzinger</surname> <given-names>C</given-names></name> <name><surname>Gattringer</surname> <given-names>T</given-names></name> <name><surname>Eppinger</surname> <given-names>S</given-names></name> <name><surname>Niederkorn</surname> <given-names>K</given-names></name> <name><surname>Horner</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Prevalence and short-term changes of cognitivedysfunction in young ischemic stroke patients</article-title>. <source>Eur J Neurol.</source> (<year>2018</year>) <volume>26</volume>:<fpage>727</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1111/ene.13879</pub-id><pub-id pub-id-type="pmid">30489673</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tib&#x000E6;k</surname> <given-names>M</given-names></name> <name><surname>Dehlendorff</surname> <given-names>C</given-names></name> <name><surname>J&#x000F8;rgensen</surname> <given-names>HS</given-names></name> <name><surname>Forchhammer</surname> <given-names>HB</given-names></name> <name><surname>Johnsen</surname> <given-names>SP</given-names></name> <name><surname>Kammersgaard</surname> <given-names>LP</given-names></name></person-group>. <article-title>Increasing incidence of hospitalization for stroke and transient ischemic attack in young adults: a registry-based study</article-title>. <source>J Am Heart Assoc.</source> (<year>2016</year>) <volume>5</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1161/JAHA.115.003158</pub-id><pub-id pub-id-type="pmid">27169547</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ekker</surname> <given-names>MS</given-names></name> <name><surname>Boot</surname> <given-names>EM</given-names></name> <name><surname>Singhal</surname> <given-names>AB</given-names></name> <name><surname>Tan</surname> <given-names>KS</given-names></name> <name><surname>Debette</surname> <given-names>S</given-names></name> <name><surname>Tuladhar</surname> <given-names>AM</given-names></name> <etal/></person-group>. <article-title>Epidemiology, aetiology, and management of ischaemic stroke in young adults</article-title>. <source>Lancet Neurol.</source> (<year>2018</year>) <volume>17</volume>:<fpage>790</fpage>&#x02013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(18)30233-3</pub-id><pub-id pub-id-type="pmid">30129475</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maaijwee</surname> <given-names>N A.</given-names></name> <name><surname>MM</surname></name> <name><surname>Rutten-Jacobs</surname> <given-names>LC</given-names></name> <name><surname>Schaapsmeerders</surname> <given-names>P</given-names></name> <name><surname>van Dijk</surname> <given-names>EJ</given-names></name> <name><surname>de Leeuw</surname> <given-names>F-E</given-names></name></person-group>. <article-title>Ischaemic stroke in young adults: risk factors and long-term consequences</article-title>. <source>Nat Rev Neurol.</source> (<year>2014</year>) <volume>10</volume>:<fpage>315</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.72</pub-id><pub-id pub-id-type="pmid">24776923</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Donnell</surname> <given-names>MJ</given-names></name> <name><surname>Xavier</surname> <given-names>D</given-names></name> <name><surname>Liu</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Chin</surname> <given-names>SL</given-names></name> <name><surname>Rao-Melacini</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study</article-title>. <source>Lancet.</source> (<year>2010</year>) <volume>376</volume>:<fpage>112</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)60834-3</pub-id><pub-id pub-id-type="pmid">20561675</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Sarnowski</surname> <given-names>B</given-names></name> <name><surname>Putaala</surname> <given-names>J</given-names></name> <name><surname>Grittner</surname> <given-names>U</given-names></name> <name><surname>Gaertner</surname> <given-names>B</given-names></name> <name><surname>Schminke</surname> <given-names>U</given-names></name> <name><surname>Curtze</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study</article-title>. <source>Stroke.</source> (<year>2013</year>) <volume>44</volume>:<fpage>119</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.112.665190</pub-id><pub-id pub-id-type="pmid">23150649</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakakibara</surname> <given-names>BM</given-names></name> <name><surname>Kim</surname> <given-names>AJ</given-names></name> <name><surname>Eng</surname> <given-names>JJ</given-names></name></person-group>. <article-title>A systematic review and meta-analysis on self-management for improving risk factor control in stroke patients</article-title>. <source>Int J Behav Med</source>. (<year>2017</year>) <fpage>24</fpage>. <pub-id pub-id-type="doi">10.1007/s12529-016-9582-7</pub-id><pub-id pub-id-type="pmid">27469998</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boehme</surname> <given-names>C</given-names></name> <name><surname>Toell</surname> <given-names>T</given-names></name> <name><surname>Mayer</surname> <given-names>L</given-names></name> <name><surname>Domig</surname> <given-names>L</given-names></name> <name><surname>Pechlaner</surname> <given-names>R</given-names></name> <name><surname>Willeit</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>The dimension of preventable stroke in a large representative patient cohort</article-title>. <source>Neurology.</source> (<year>2019</year>) <volume>93</volume>:<fpage>E2121</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000008573</pub-id><pub-id pub-id-type="pmid">31672716</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grau-Pellicer</surname> <given-names>M</given-names></name> <name><surname>Lalanza</surname> <given-names>JF</given-names></name> <name><surname>Jovell-Fern&#x000E1;ndez</surname> <given-names>E</given-names></name> <name><surname>Capdevila</surname> <given-names>L</given-names></name></person-group>. <article-title>Impact of mHealth technology on adherence to healthy PA after stroke: a randomized study</article-title>. <source>Top Stroke Rehabil.</source> (<year>2020</year>) <volume>27</volume>:<fpage>354</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1080/10749357.2019.1691816</pub-id><pub-id pub-id-type="pmid">31790639</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname> <given-names>SP</given-names></name> <name><surname>Terblanche</surname> <given-names>M</given-names></name> <name><surname>Perea</surname> <given-names>J</given-names></name> <name><surname>Lillard</surname> <given-names>H</given-names></name> <name><surname>DeLaPena</surname> <given-names>C</given-names></name> <name><surname>Grinage</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>mHealth intervention applications for adults living with the effects of stroke: a scoping review</article-title>. <source>Arch Rehabil Res Clin Transl.</source> (<year>2021</year>) <volume>3</volume>:<fpage>100095</fpage>. <pub-id pub-id-type="doi">10.1016/j.arrct.2020.100095</pub-id><pub-id pub-id-type="pmid">33778470</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthi</surname> <given-names>R</given-names></name> <name><surname>Hale</surname> <given-names>L</given-names></name> <name><surname>Barker-Collo</surname> <given-names>S</given-names></name> <name><surname>Theadom</surname> <given-names>A</given-names></name> <name><surname>Bhattacharjee</surname> <given-names>R</given-names></name> <name><surname>George</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Mobile technology for primary stroke prevention</article-title>. <source>Stroke.</source> (<year>2019</year>) <volume>50</volume>:<fpage>196</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.118.023058</pub-id><pub-id pub-id-type="pmid">30580699</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berenguer</surname> <given-names>A</given-names></name> <name><surname>Goncalves</surname> <given-names>J</given-names></name> <name><surname>Hosio</surname> <given-names>S</given-names></name> <name><surname>Ferreira</surname> <given-names>D</given-names></name> <name><surname>Anagnostopoulos</surname> <given-names>T</given-names></name> <name><surname>Kostakos</surname> <given-names>V</given-names></name></person-group>. <article-title>Are Smartphones Ubiquitous? : An in-depth survey of smartphone adoption by seniors</article-title>. <source>IEEE Consum Electron Mag.</source> (<year>2017</year>) <volume>6</volume>:<fpage>104</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1109/MCE.2016.2614524</pub-id><pub-id pub-id-type="pmid">27295638</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Aitken</surname> <given-names>M</given-names></name> <name><surname>Clancy</surname> <given-names>B</given-names></name> <name><surname>Nass</surname> <given-names>D</given-names></name></person-group>. <source>The growing value of digital health: evidence impact on human health the healthcare system</source>. <publisher-loc>New Jersey, NJ</publisher-loc>: <publisher-name>IQVIA Institute for Human Data Science</publisher-name> (<year>2017</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.iqvia.com/insights/the-iqvia-institute/reports/the-growing-value-of-digital-health">https://www.iqvia.com/insights/the-iqvia-institute/reports/the-growing-value-of-digital-health</ext-link></citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fruhwirth</surname> <given-names>V</given-names></name> <name><surname>Enzinger</surname> <given-names>C</given-names></name> <name><surname>Weiss</surname> <given-names>E</given-names></name> <name><surname>Schwerdtfeger</surname> <given-names>A</given-names></name> <name><surname>Gattringer</surname> <given-names>T</given-names></name> <name><surname>Pinter</surname> <given-names>D</given-names></name></person-group>. <article-title>Use of smartphone apps in secondary stroke prevention</article-title>. <source>Wiener Medizinische Wochenschrift</source>. (<year>2020</year>) <volume>170</volume>:<fpage>41</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/s10354-019-00707-3</pub-id><pub-id pub-id-type="pmid">31535230</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamal</surname> <given-names>AK</given-names></name> <name><surname>Shaikh</surname> <given-names>Q</given-names></name> <name><surname>Pasha</surname> <given-names>O</given-names></name> <name><surname>Azam</surname> <given-names>I</given-names></name> <name><surname>Islam</surname> <given-names>M</given-names></name> <name><surname>Memon</surname> <given-names>AA</given-names></name> <etal/></person-group>. <article-title>A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored Short Messaging Service (SMS)-SMS4Stroke study</article-title>. <source>BMC Neurol.</source> (<year>2015</year>) <volume>15</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s12883-015-0471-5</pub-id><pub-id pub-id-type="pmid">26486857</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ovbiagele</surname> <given-names>B</given-names></name> <name><surname>Jenkins</surname> <given-names>C</given-names></name> <name><surname>Patel</surname> <given-names>S</given-names></name> <name><surname>Brunner-Jackson</surname> <given-names>B</given-names></name> <name><surname>Anderson</surname> <given-names>A</given-names></name> <name><surname>Saulson</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Mobile health medication adherence and blood pressure control in recent stroke patients</article-title>. <source>J Neurol Sci.</source> (<year>2015</year>) <volume>358</volume>:<fpage>535</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2015.10.008</pub-id><pub-id pub-id-type="pmid">26463572</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Requena</surname> <given-names>M</given-names></name> <name><surname>Montiel</surname> <given-names>E</given-names></name> <name><surname>Baladas</surname> <given-names>M</given-names></name> <name><surname>Muchada</surname> <given-names>M</given-names></name> <name><surname>Boned</surname> <given-names>S</given-names></name> <name><surname>L&#x000F3;pez</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Farmalarm: application for mobile devices improves risk factor control after stroke</article-title>. <source>Stroke.</source> (<year>2019</year>) <volume>50</volume>:<fpage>1819</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.118.024355</pub-id><pub-id pub-id-type="pmid">31167621</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname> <given-names>WK</given-names></name> <name><surname>Kang</surname> <given-names>J</given-names></name> <name><surname>Jeon</surname> <given-names>K</given-names></name> <name><surname>Lee</surname> <given-names>K</given-names></name> <name><surname>Lee</surname> <given-names>S</given-names></name> <name><surname>Kim</surname> <given-names>JH</given-names></name> <etal/></person-group>. <article-title>Feasibility of using mobile applications for the monitoring and management of stroke-associated risk factors</article-title>. <source>J Clin Neurol.</source> (<year>2015</year>) <volume>11</volume>:<fpage>142</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3988/jcn.2015.11.2.142</pub-id><pub-id pub-id-type="pmid">25851892</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname> <given-names>L</given-names></name> <name><surname>Wyke</surname> <given-names>S</given-names></name> <name><surname>Brewster</surname> <given-names>S</given-names></name> <name><surname>Sattar</surname> <given-names>N</given-names></name> <name><surname>Gill</surname> <given-names>JMR</given-names></name> <name><surname>Alexander</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Increasing physical activity in stroke survivors using STARFISH, an interactive mobile phone application: A pilot study</article-title>. <source>Top Stroke Rehabil.</source> (<year>2016</year>) <volume>23</volume>:<fpage>170</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1080/10749357.2015.1122266</pub-id><pub-id pub-id-type="pmid">27077973</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denham</surname> <given-names>AMJ</given-names></name> <name><surname>Halpin</surname> <given-names>S</given-names></name> <name><surname>Twyman</surname> <given-names>L</given-names></name> <name><surname>Guillaumier</surname> <given-names>A</given-names></name> <name><surname>Bonevski</surname> <given-names>B</given-names></name></person-group>. <article-title>Prevent 2 <sup>nd</sup> Stroke: a pilot study of an online secondary prevention program for stroke survivors</article-title>. <source>Aust N Z J Public Health</source>. (<year>2018</year>) <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/1753-6405.12794</pub-id><pub-id pub-id-type="pmid">29888829</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamwesiga</surname> <given-names>JT</given-names></name> <name><surname>Eriksson</surname> <given-names>GM</given-names></name> <name><surname>Tham</surname> <given-names>K</given-names></name> <name><surname>Fors</surname> <given-names>U</given-names></name> <name><surname>Ndiwalana</surname> <given-names>A</given-names></name> <name><surname>von Koch</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>A feasibility study of a mobile phone supported family-centred ADL intervention, F&#x00040;ce<sup>TM</sup>, after stroke in Uganda</article-title>. <source>Global Health.</source> (<year>2018</year>) <volume>14</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1186/s12992-018-0400-7</pub-id><pub-id pub-id-type="pmid">30111333</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarfo</surname> <given-names>FS</given-names></name> <name><surname>Adusei</surname> <given-names>N</given-names></name> <name><surname>Ampofo</surname> <given-names>M</given-names></name> <name><surname>Kpeme</surname> <given-names>FK</given-names></name> <name><surname>Ovbiagele</surname> <given-names>B</given-names></name></person-group>. <article-title>Pilot trial of a tele-rehab intervention to improve outcomes after stroke in Ghana: A feasibility and user satisfaction study</article-title>. <source>J Neurol Sci.</source> (<year>2018</year>) <volume>387</volume>:<fpage>94</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2018.01.039</pub-id><pub-id pub-id-type="pmid">29571880</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sureshkumar</surname> <given-names>K</given-names></name> <name><surname>Murthy</surname> <given-names>GVS</given-names></name> <name><surname>Natarajan</surname> <given-names>S</given-names></name> <name><surname>Naveen</surname> <given-names>C</given-names></name> <name><surname>Goenka</surname> <given-names>S</given-names></name> <name><surname>Kuper</surname> <given-names>H</given-names></name></person-group>. <article-title>Evaluation of the feasibility and acceptability of the &#x0201C;Care for Stroke&#x0201D; intervention in India, a smartphoneenabled, carer-supported, educational intervention for management of disability following stroke</article-title>. <source>BMJ Open</source>. (<year>2016</year>) <fpage>6</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2015-009243</pub-id><pub-id pub-id-type="pmid">26839011</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarfo</surname> <given-names>F</given-names></name> <name><surname>Treiber</surname> <given-names>F</given-names></name> <name><surname>Gebregziabher</surname> <given-names>M</given-names></name> <name><surname>Adamu</surname> <given-names>S</given-names></name> <name><surname>Patel</surname> <given-names>S</given-names></name> <name><surname>Nichols</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>PINGS (Phone-based intervention under nurse guidance after stroke) interim results of a pilot randomized controlled trial</article-title>. <source>Stroke.</source> (<year>2018</year>) <volume>49</volume>:<fpage>236</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.117.019591</pub-id><pub-id pub-id-type="pmid">29222227</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>Y-N</given-names></name> <name><surname>Shen</surname> <given-names>H-N</given-names></name> <name><surname>Lin</surname> <given-names>C-Y</given-names></name> <name><surname>Elwyn</surname> <given-names>G</given-names></name> <name><surname>Huang</surname> <given-names>S-C</given-names></name> <name><surname>Wu</surname> <given-names>T-F</given-names></name> <etal/></person-group>. <article-title>Does a Mobile app improve patients&#x00027; knowledge of stroke risk factors and health-related quality of life in patients with stroke? A randomized controlled trial</article-title>. <source>BMC Med Inform Decis Mak.</source> (<year>2019</year>) <volume>19</volume>:<fpage>282</fpage>. <pub-id pub-id-type="doi">10.1186/s12911-019-1000-z</pub-id><pub-id pub-id-type="pmid">31864348</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname> <given-names>I</given-names></name> <name><surname>Berg</surname> <given-names>A</given-names></name> <name><surname>Grathwohl</surname> <given-names>DK</given-names></name> <name><surname>Keul</surname> <given-names>J</given-names></name></person-group>. <article-title>Freiburg Questionnaire of physical activity&#x02013;development, evaluation and application</article-title>. <source>Soz Praventivmed.</source> (<year>1999</year>) <volume>44</volume>:<fpage>55</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1007/BF01667127</pub-id><pub-id pub-id-type="pmid">10407953</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>RAH</given-names></name> <name><surname>Wallentin</surname> <given-names>L</given-names></name> <name><surname>Benatar</surname> <given-names>J</given-names></name> <name><surname>Danchin</surname> <given-names>N</given-names></name> <name><surname>Hagstr&#x000F6;m</surname> <given-names>E</given-names></name> <name><surname>Held</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease</article-title>. <source>Eur Heart J.</source> (<year>2016</year>) <volume>37</volume>:<fpage>1993</fpage>&#x02013;<lpage>2001</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehw125</pub-id><pub-id pub-id-type="pmid">27109584</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname> <given-names>NJ</given-names></name> <name><surname>Brooks</surname> <given-names>R</given-names></name></person-group>. <article-title>EQ-5D and the EuroQol group: past, present and future</article-title>. <source>Appl Health Econ Health Policy.</source> (<year>2017</year>) <volume>15</volume>:<fpage>127</fpage>. <pub-id pub-id-type="doi">10.1007/s40258-017-0310-5</pub-id><pub-id pub-id-type="pmid">28194657</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beekman</surname> <given-names>E</given-names></name> <name><surname>Verhagen</surname> <given-names>A</given-names></name></person-group>. <article-title>Clinimetrics: Hospital anxiety and depression scale</article-title>. <source>J Physiother.</source> (<year>2018</year>) <volume>64</volume>:<fpage>198</fpage>. <pub-id pub-id-type="doi">10.1016/j.jphys.2018.04.003</pub-id><pub-id pub-id-type="pmid">29895416</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grice</surname> <given-names>KO</given-names></name> <name><surname>Vogel</surname> <given-names>KA</given-names></name> <name><surname>Le</surname> <given-names>V</given-names></name> <name><surname>Mitchell</surname> <given-names>A</given-names></name> <name><surname>Muniz</surname> <given-names>S</given-names></name> <name><surname>Vollmer</surname> <given-names>MA</given-names></name></person-group>. <article-title>Adult norms for a commercially available nine hole peg test for finger dexterity</article-title>. <source>Am J Occup Ther.</source> (<year>2003</year>) <volume>57</volume>:<fpage>570</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.5014/ajot.57.5.570</pub-id><pub-id pub-id-type="pmid">14527120</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheeran</surname> <given-names>P</given-names></name> <name><surname>Maki</surname> <given-names>A</given-names></name> <name><surname>Montanaro</surname> <given-names>E</given-names></name> <name><surname>Avishai-Yitshak</surname> <given-names>A</given-names></name> <name><surname>Bryan</surname> <given-names>A</given-names></name> <name><surname>Klein</surname> <given-names>WMP</given-names></name> <etal/></person-group>. <article-title>The impact of changing attitudes, norms, and self-efficacy on health-related intentions and behavior: A meta-analysis</article-title>. <source>Heal Psychol.</source> (<year>2016</year>) <volume>35</volume>:<fpage>1178</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1037/hea0000387</pub-id><pub-id pub-id-type="pmid">27280365</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hagger</surname> <given-names>MS</given-names></name> <name><surname>Luszczynska</surname> <given-names>A</given-names></name></person-group>. <article-title>Implementation Intention and Action Planning Interventions in Health Contexts: State of the Research and Proposals for the Way Forward</article-title>. <source>Appl Psychol Heal Well-Being.</source> (<year>2014</year>) <volume>6</volume>:<fpage>1</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1111/aphw.12017</pub-id><pub-id pub-id-type="pmid">24591064</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quattrocchi</surname> <given-names>G</given-names></name> <name><surname>Greenwood</surname> <given-names>R</given-names></name> <name><surname>Rothwell</surname> <given-names>JC</given-names></name> <name><surname>Galea</surname> <given-names>JM</given-names></name> <name><surname>Bestmann</surname> <given-names>S</given-names></name></person-group>. <article-title>Reward and punishment enhance motor adaptation in stroke</article-title>. <source>J Neurol Neurosurg Psychiatry.</source> (<year>2017</year>) <volume>88</volume>:<fpage>730</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2016-314728</pub-id><pub-id pub-id-type="pmid">28377451</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname> <given-names>B</given-names></name> <name><surname>A</surname></name></person-group>. <article-title>review and analysis of the use of &#x02018;habit&#x00027; in understanding, predicting and influencing health-related behaviour</article-title>. <source>Health Psychol Rev.</source> (<year>2015</year>) <volume>9</volume>:<fpage>277</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1080/17437199.2013.876238</pub-id><pub-id pub-id-type="pmid">25207647</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname> <given-names>LR</given-names></name> <name><surname>Whittinghill</surname> <given-names>DM</given-names></name></person-group>. <article-title>Intrinsic or extrinsic? Using videogames to motivate stroke survivors: a systematic review</article-title>. <source>Games Health J.</source> (<year>2015</year>) <volume>4</volume>:<fpage>253</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1089/g4h.2014.0074</pub-id><pub-id pub-id-type="pmid">26182071</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bovend&#x00027;Eerdt</surname> <given-names>TJ</given-names></name> <name><surname>Botell</surname> <given-names>RE</given-names></name> <name><surname>Wade</surname> <given-names>DT</given-names></name></person-group>. <article-title>Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide</article-title>. <source>Clin Rehabil</source>. (<year>2009</year>) <volume>23</volume>:<fpage>352</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1177/0269215508101741</pub-id><pub-id pub-id-type="pmid">19237435</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson-Smith</surname> <given-names>G</given-names></name> <name><surname>Harmer</surname> <given-names>C</given-names></name> <name><surname>Sheeran</surname> <given-names>R</given-names></name> <name><surname>Bellino Vallo</surname> <given-names>E</given-names></name></person-group>. <article-title>Couples&#x00027; coping after stroke-a pilot intervention study</article-title>. <source>Rehabil Nurs.</source> (<year>2016</year>) <volume>41</volume>:<fpage>218</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1002/rnj.213</pub-id><pub-id pub-id-type="pmid">25865578</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname> <given-names>T</given-names></name> <name><surname>Haley</surname> <given-names>E</given-names></name> <name><surname>Eliasziw</surname> <given-names>M</given-names></name> <name><surname>Hoyte</surname> <given-names>K</given-names></name></person-group>. <article-title>Education in stroke prevention: efficacy of an educational counselling intervention to increase knowledge in stroke survivors</article-title>. <source>Can J Neurosci Nurs.</source> (<year>2007</year>) <volume>29</volume>:<fpage>13</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">18240627</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kontou</surname> <given-names>E</given-names></name> <name><surname>Kettlewell</surname> <given-names>J</given-names></name> <name><surname>Condon</surname> <given-names>L</given-names></name> <name><surname>Thomas</surname> <given-names>S</given-names></name> <name><surname>Lee</surname> <given-names>AR</given-names></name> <name><surname>Sprigg</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>A scoping review of psychoeducational interventions for people after transient ischemic attack and minor stroke</article-title>. <source>Top Stroke Rehabil.</source> (<year>2021</year>) <volume>28</volume>:<fpage>390</fpage>&#x02013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1080/10749357.2020.1818473</pub-id><pub-id pub-id-type="pmid">32996432</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname> <given-names>TJ</given-names></name> <name><surname>Baum</surname> <given-names>CM</given-names></name> <name><surname>Lee</surname> <given-names>D</given-names></name> <name><surname>Hammel</surname> <given-names>J</given-names></name></person-group>. <article-title>The development of the improving participation after stroke self-management program (IPASS): An exploratory randomized clinical study</article-title>. <source>Top Stroke Rehabil.</source> (<year>2016</year>) <volume>23</volume>:<fpage>284</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1080/10749357.2016.1155278</pub-id><pub-id pub-id-type="pmid">27077987</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbate</surname> <given-names>M</given-names></name> <name><surname>Gallardo-Alfaro</surname> <given-names>L</given-names></name> <name><surname>Bibiloni</surname> <given-names>MDM</given-names></name> <name><surname>Tur</surname> <given-names>JA</given-names></name></person-group>. <article-title>Efficacy of dietary intervention or in combination with exercise on primary prevention of cardiovascular disease: A systematic review</article-title>. <source>Nutr Metab Cardiovasc Dis.</source> (<year>2020</year>) <volume>30</volume>:<fpage>1080</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2020.02.020</pub-id><pub-id pub-id-type="pmid">32448717</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname> <given-names>JW</given-names></name> <name><surname>Neill</surname> <given-names>JT</given-names></name></person-group>. <article-title>Coping strategies and the development of psychological resilience</article-title>. <source>J Outdoor Environ Educ</source>. (<year>2017</year>) <volume>20</volume>:<fpage>47</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1007/BF03401002</pub-id></citation>
</ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>V</given-names></name> <name><surname>Darling</surname> <given-names>S</given-names></name> <name><surname>Mackay</surname> <given-names>M</given-names></name> <name><surname>Monagle</surname> <given-names>P</given-names></name> <name><surname>Greenham</surname> <given-names>M</given-names></name> <name><surname>Cooper</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Cognitive resilience following paediatric stroke: Biological and environmental predictors</article-title>. <source>Eur J Paediatr Neurol.</source> (<year>2020</year>) <volume>25</volume>:<fpage>52</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2019.11.011</pub-id><pub-id pub-id-type="pmid">31866101</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gyawali</surname> <given-names>P</given-names></name> <name><surname>Chow</surname> <given-names>WZ</given-names></name> <name><surname>Hinwood</surname> <given-names>M</given-names></name> <name><surname>Kluge</surname> <given-names>M</given-names></name> <name><surname>English</surname> <given-names>C</given-names></name> <name><surname>Ong</surname> <given-names>LK</given-names></name> <etal/></person-group>. <article-title>Opposing associations of stress and resilience with functional outcomes in stroke survivors in the chronic phase of stroke: a cross-sectional study</article-title>. <source>Front Neurol.</source> (<year>2020</year>) <volume>11</volume>:<fpage>230</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2020.00230</pub-id><pub-id pub-id-type="pmid">32390923</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aarnes</surname> <given-names>R</given-names></name> <name><surname>Stubberud</surname> <given-names>J</given-names></name> <name><surname>Lerdal</surname> <given-names>A</given-names></name> <name><surname>A</surname></name></person-group>. <article-title>literature review of factors associated with fatigue after stroke and a proposal for a framework for clinical utility</article-title>. <source>Neuropsychol Rehabil.</source> (<year>2020</year>) <volume>30</volume>:<fpage>1449</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1080/09602011.2019.1589530</pub-id><pub-id pub-id-type="pmid">30905262</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>M</given-names></name> <name><surname>Ferrari</surname> <given-names>M</given-names></name> <name><surname>Patella</surname> <given-names>R</given-names></name> <name><surname>Marra</surname> <given-names>C</given-names></name> <name><surname>Rasura</surname> <given-names>M</given-names></name></person-group>. <article-title>Neuropsychological findings in young-adult stroke patients</article-title>. <source>Arch Clin Neuropsychol.</source> (<year>2007</year>) <volume>22</volume>:<fpage>133</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.acn.2006.09.005</pub-id><pub-id pub-id-type="pmid">17169527</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celis-Morales</surname> <given-names>CA</given-names></name> <name><surname>Perez-Bravo</surname> <given-names>F</given-names></name> <name><surname>Iba&#x000F1;ez</surname> <given-names>L</given-names></name> <name><surname>Salas</surname> <given-names>C</given-names></name> <name><surname>Bailey</surname> <given-names>MES</given-names></name> <name><surname>Gill</surname> <given-names>JMR</given-names></name></person-group>. <article-title>Objective vs. self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers</article-title> <person-group person-group-type="editor"><name><surname>Dasgupta</surname> <given-names>K</given-names></name></person-group>, editor. <source>PLoS ONE.</source> (<year>2012</year>) <volume>7</volume>:<fpage>e36345</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0036345</pub-id><pub-id pub-id-type="pmid">22590532</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname> <given-names>Y-L</given-names></name> <name><surname>Huang</surname> <given-names>S-J</given-names></name> <name><surname>Lai</surname> <given-names>C-H</given-names></name> <name><surname>Huang</surname> <given-names>C-C</given-names></name> <name><surname>Jiang</surname> <given-names>S-H</given-names></name> <name><surname>Li</surname> <given-names>S-R</given-names></name> <etal/></person-group>. <article-title>Validation of self-reported smoking with urinary cotinine levels and influence of second-hand smoke among conscripts</article-title>. <source>Sci Rep.</source> (<year>2017</year>) <volume>7</volume>:<fpage>15462</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-15526-y</pub-id><pub-id pub-id-type="pmid">29133917</pub-id></citation></ref>
</ref-list> 
</back>
</article> 